Sustained Release of Salicylic Acid for Halting Peri-Implantitis Progression in Healthy and Hyperglycemic Systemic Conditions: A Gottingen Minipig Model

Loading...
Thumbnail Image
Penn collection
School of Dental Medicine::Departmental Papers (Dental)
Degree type
Discipline
Dentistry
Subject
dental implants
metabolic diseases
osseointegration
peri-implantitis
treatment
Funder
Grant number
Copyright date
2024-05-13
Distributor
Related resources
Author
Bergamo, Edmara T. P.
Witek, Lukasz
Ramalho, Ilana Santos
Lopes, Adolfo Coelho de Oliveira
Nayak, Vasudev Vivekanand
Torroni, Andrea
Slavin, Blaire V.
Bonfante, Estevam A.
Uhrich, Kathryn E.
Graves, Dana T.
Contributor
Abstract

To develop a peri-implantitis model in a Gottingen minipig and evaluate the effect of local application of salicylic acid poly(anhydride-ester) (SAPAE) on peri-implantitis progression in healthy, metabolic syndrome (MS), and type-2 diabetes mellitus (T2DM) subjects. Eighteen animals were allocated to three groups: (i) control, (ii) MS (diet for obesity induction), and (iii) T2DM (diet plus streptozotocin for T2DM induction). Maxillary and mandible premolars and first molar were extracted. After 3 months of healing, four implants per side were placed in both jaws of each animal. After 2 months, peri-implantitis was induced by plaque formation using silk ligatures. SAPAE polymer was mixed with mineral oil (3.75 mg/μL) and topically applied biweekly for up to 60 days to halt peri-implantitis progression. Periodontal probing was used to assess pocket depth over time, followed by histomorphologic analysis of harvested samples. The adopted protocol resulted in the onset of peri-implantitis, with healthy minipigs taking twice as long to reach the same level of probing depth relative to MS and T2DM subjects (∼3.0 mm), irrespective of jaw. In a qualitative analysis, SAPAE therapy revealed decreased levels of inflammation in the normoglycemic, MS, and T2DM groups. SAPAE application around implants significantly reduced the progression of peri-implantitis after ∼15 days of therapy, with ∼30% lower probing depth for all systemic conditions and similar rates of probing depth increase per week between the control and SAPAE groups. MS and T2DM conditions presented a faster progression of the peri-implant pocket depth. SAPAE treatment reduced peri-implantitis progression in healthy, MS, and T2DM groups. © 2024 The Authors. Published by American Chemical Society.

Advisor
Date Range for Data Collection (Start Date)
Date Range for Data Collection (End Date)
Digital Object Identifier
Series name and number
Publication date
2024-05-13
Journal title
ACS Biomaterials Science and Engineering
Volume number
Issue number
Publisher
ACS Publications
Publisher DOI
10.1021/acsbiomaterials.4c00161
Journal Issue
Comments
Recommended citation
Collection